Concepts (86)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Kidney | 10 | 2023 | 139 | 1.970 |
Why?
|
| Kidney Diseases | 6 | 2014 | 68 | 1.860 |
Why?
|
| Renal Dialysis | 4 | 2016 | 73 | 1.440 |
Why?
|
| Biopsy, Needle | 6 | 2021 | 100 | 1.220 |
Why?
|
| Nephrology | 3 | 2018 | 11 | 1.080 |
Why?
|
| Arteriovenous Shunt, Surgical | 3 | 2016 | 17 | 0.930 |
Why?
|
| Kidney Failure, Chronic | 3 | 2016 | 108 | 0.810 |
Why?
|
| Nephrosis, Lipoid | 1 | 2019 | 11 | 0.610 |
Why?
|
| Thrombosis | 2 | 2016 | 37 | 0.560 |
Why?
|
| Polyuria | 1 | 2017 | 2 | 0.540 |
Why?
|
| Antidiuretic Agents | 1 | 2017 | 2 | 0.540 |
Why?
|
| Hyponatremia | 1 | 2017 | 6 | 0.540 |
Why?
|
| Lupus Nephritis | 2 | 2015 | 25 | 0.540 |
Why?
|
| Deamino Arginine Vasopressin | 1 | 2017 | 5 | 0.540 |
Why?
|
| Biopsy | 4 | 2018 | 184 | 0.520 |
Why?
|
| Hematuria | 2 | 2014 | 14 | 0.490 |
Why?
|
| Education, Medical, Continuing | 1 | 2014 | 30 | 0.430 |
Why?
|
| Clinical Competence | 2 | 2018 | 198 | 0.400 |
Why?
|
| Urologic Surgical Procedures | 1 | 2012 | 8 | 0.380 |
Why?
|
| Postoperative Hemorrhage | 1 | 2012 | 20 | 0.380 |
Why?
|
| Pregnancy Complications | 1 | 2012 | 43 | 0.370 |
Why?
|
| Humans | 19 | 2023 | 24703 | 0.360 |
Why?
|
| Internship and Residency | 1 | 2014 | 199 | 0.340 |
Why?
|
| Porphyria Cutanea Tarda | 1 | 2010 | 3 | 0.330 |
Why?
|
| Skin Diseases, Vesiculobullous | 1 | 2010 | 5 | 0.330 |
Why?
|
| Constriction, Pathologic | 3 | 2016 | 21 | 0.290 |
Why?
|
| Male | 10 | 2021 | 13669 | 0.260 |
Why?
|
| Prospective Studies | 5 | 2021 | 1612 | 0.220 |
Why?
|
| Middle Aged | 7 | 2021 | 8294 | 0.200 |
Why?
|
| Glomerulonephritis, IGA | 1 | 2023 | 7 | 0.200 |
Why?
|
| Immunosuppressive Agents | 2 | 2023 | 104 | 0.190 |
Why?
|
| Prognosis | 2 | 2023 | 674 | 0.170 |
Why?
|
| Needles | 1 | 2021 | 17 | 0.170 |
Why?
|
| Aged | 5 | 2021 | 8382 | 0.160 |
Why?
|
| Prednisone | 1 | 2019 | 61 | 0.150 |
Why?
|
| Nephrotic Syndrome | 1 | 2019 | 22 | 0.150 |
Why?
|
| Nephrologists | 1 | 2018 | 3 | 0.150 |
Why?
|
| Radiologists | 1 | 2018 | 7 | 0.150 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2019 | 75 | 0.150 |
Why?
|
| Adult | 6 | 2021 | 7255 | 0.150 |
Why?
|
| Recurrence | 1 | 2019 | 281 | 0.140 |
Why?
|
| Female | 7 | 2021 | 14048 | 0.140 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2018 | 99 | 0.140 |
Why?
|
| Ultrasonography, Interventional | 2 | 2018 | 61 | 0.140 |
Why?
|
| Self Medication | 1 | 2017 | 3 | 0.130 |
Why?
|
| Osmolar Concentration | 1 | 2017 | 16 | 0.130 |
Why?
|
| Urinalysis | 1 | 2017 | 8 | 0.130 |
Why?
|
| Hypothalamus | 1 | 2017 | 13 | 0.130 |
Why?
|
| Risk Factors | 3 | 2012 | 2099 | 0.130 |
Why?
|
| Atrial Fibrillation | 1 | 2017 | 79 | 0.120 |
Why?
|
| Receptors, Urokinase Plasminogen Activator | 1 | 2015 | 16 | 0.120 |
Why?
|
| Glomerular Filtration Rate | 1 | 2015 | 35 | 0.120 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 1 | 2015 | 30 | 0.120 |
Why?
|
| Automation | 1 | 2014 | 9 | 0.120 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 250 | 0.110 |
Why?
|
| Image-Guided Biopsy | 1 | 2014 | 28 | 0.110 |
Why?
|
| Severity of Illness Index | 2 | 2009 | 814 | 0.110 |
Why?
|
| Adolescent | 3 | 2014 | 1992 | 0.110 |
Why?
|
| Young Adult | 3 | 2014 | 1847 | 0.100 |
Why?
|
| Logistic Models | 1 | 2014 | 365 | 0.100 |
Why?
|
| Multivariate Analysis | 1 | 2014 | 304 | 0.100 |
Why?
|
| Biomarkers | 1 | 2015 | 520 | 0.100 |
Why?
|
| Age Factors | 2 | 2012 | 728 | 0.090 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2011 | 14 | 0.090 |
Why?
|
| Pregnancy | 1 | 2012 | 315 | 0.090 |
Why?
|
| Hemorrhage | 1 | 2011 | 66 | 0.090 |
Why?
|
| Sex Factors | 1 | 2012 | 443 | 0.090 |
Why?
|
| Ultrasonography, Doppler | 1 | 2009 | 15 | 0.080 |
Why?
|
| Glucose | 1 | 2009 | 46 | 0.080 |
Why?
|
| Incidence | 1 | 2011 | 697 | 0.080 |
Why?
|
| Equipment Design | 2 | 2021 | 122 | 0.070 |
Why?
|
| Time Factors | 2 | 2018 | 1327 | 0.070 |
Why?
|
| United States | 2 | 2011 | 1873 | 0.070 |
Why?
|
| Reproducibility of Results | 2 | 2021 | 598 | 0.060 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 4509 | 0.060 |
Why?
|
| Kidney Glomerulus | 1 | 2023 | 39 | 0.050 |
Why?
|
| Retrospective Studies | 2 | 2023 | 3156 | 0.040 |
Why?
|
| Fellowships and Scholarships | 1 | 2018 | 33 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2004 | 3208 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2014 | 202 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 1671 | 0.020 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 1 | 2009 | 8 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2009 | 69 | 0.020 |
Why?
|
| Renal Replacement Therapy | 1 | 2005 | 18 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 2005 | 61 | 0.010 |
Why?
|
| Prevalence | 1 | 2005 | 411 | 0.010 |
Why?
|